L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3088
ETF rank
โ‚น1.83 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น1,242
Share price
0.21%
Change (1 day)
37.96%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of February 2026: 0.49%